PARENTERAL CONTROLLED DRUG DELIVERY SYSTEM A MODERN FORMULATION APPROACH

The Parenteral administration route is the most common and efficient for delivery of active drug substances with poor bioavailability and the drugs with a narrow therapeutic index. But parenteral route offers rapid onset of action with rapid declines of systemic drug level. For the sake of effective treatment, it is often desirable to maintain systemic drug levels within the therapeutic effective concentration range for as long as treatment calls for. It requires frequent injections, which ultimately leads to patient discomfort. For this reason, the drug delivery system can reduce the total number of injections throughout the effective treatment, improve patient compliance, as well as pharmacoeconomic. These biodegradable injectable drug delivery systems offer attractive opportunities for protein delivery and could possibly extend patent life of protein drugs. This article explores various prolonged release of parenteral drug delivery systems and their strategies of preparation, their potential benefits/drawbacks, and in-vitro testing methods.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-10
DOI
https://doi.org/10.5281/zenodo.22687066
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

PARENTERAL CONTROLLED DRUG DELIVERY SYSTEM A MODERN FORMULATION APPROACH

A. Senthil2 S. Arun*1
Zenodo (CERN European Organization for Nuclear Research)
Advanced Drug Delivery Systems
article

PARENTERAL CONTROLLED DRUG DELIVERY SYSTEM A MODERN FORMULATION APPROACH

A. Senthil2 S. Arun*1
article en

Abstract

The Parenteral administration route is the most common and efficient for delivery of active drug substances with poor bioavailability and the drugs with a narrow therapeutic index. But parenteral route offers rapid onset of action with rapid declines of systemic drug level. For the sake of effective treatment, it is often desirable to maintain systemic drug levels within the therapeutic effective concentration range for as long as treatment calls for. It requires frequent injections, which ultimately leads to patient discomfort. For this reason, the drug delivery system can reduce the total number of injections throughout the effective treatment, improve patient compliance, as well as pharmacoeconomic. These biodegradable injectable drug delivery systems offer attractive opportunities for protein delivery and could possibly extend patent life of protein drugs. This article explores various prolonged release of parenteral drug delivery systems and their strategies of preparation, their potential benefits/drawbacks, and in-vitro testing methods.

Zenodo (CERN European Organization for Nuclear Research)
No poverty
Openalex Percentile: Top 12%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PARENTERAL CONTROLLED DRUG DELIVERY SYSTEM A MODERN FORMULATION APPROACH — A. Senthil2 S. Arun*1 · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS